Microfluidic nucleic acid analyzer DxLab-2A
fluorescence

microfluidic nucleic acid analyzer
microfluidic nucleic acid analyzer
microfluidic nucleic acid analyzer
microfluidic nucleic acid analyzer
Add to favorites
Compare this product
 

Characteristics

Technology
microfluidic
Analysis mode
fluorescence

Description

The system enables rapid and precise “sample in, result out” automatic and totally enclosed detection of the SARS-CoV-2. Functions such as sample lysis, nucleic acid extraction, nested amplification, and fluorescence detection are all integrated into a single microfluidic chip using a specialized fabrication method. The quick detection of SARS-CoV-2 nucleic acid is made possible by the fact that each chip can detect two samples and the entire experiment can be finished in one step within 45 mins. Features of SARS-CoV-2 Integrated Microfluidic Chip Analysis System Detection time is less than 45 mins with a manual operation duration of 1 min LoD ≤ 150 copies/mL Innovative, patented microfluidic chip technology with integrated IC, PC, and BC SARS-CoV-2 ORF1ab and N dual target genes identified in a single test

Catalogs

No catalogs are available for this product.

See all of CapitalBio Technology‘s catalogs
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.